Article révisé par les pairs
Titre:
  • The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO
Auteur:Di Cosimo, Serena; Fumagalli, Debora; Fein, Luis Enrique L.; Vinholes, Jéferson; Ng, W.M.J.; Colleoni, Marco Angelo; Ferro, Antonella; Naume, Bjorn; Patel, Ashraf; Huober, Jens; Piccart-Gebhart, Martine; Campbell, Christine; Baselga, José; de Azambuja, Evandro; Abdel Azim, Hatem Hamdy; Galli, Giulia; Bregni, Giacomo; Curigliano, Giuseppe; Criscitiello, Carmen; Izquierdo, Miguel; de la Peña, Lorena
Informations sur la publication:European journal of cancer, 89, page (42-48)
Statut de publication:Publié, 2018-01
Sujet CREF:Cancérologie
Mots-clés:Breast ultrasound
HER2 positive breast cancer
Mammography
Neoadjuvant
Targeted therapy
MeSH keywords:Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast -- diagnostic imaging
Breast Neoplasms -- chemistry -- diagnostic imaging -- drug therapy -- mortality
Female
Humans
Lapatinib
Mammography
Middle Aged
Neoadjuvant Therapy
Quinazolines -- administration & dosage -- therapeutic use
Receptor, ErbB-2 -- analysis
Trastuzumab -- administration & dosage -- therapeutic use
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2017.10.036
info:pii/S0959804917313990
info:scp/85038836808
info:pmid/29227816

Documents en relation

DI-fusion